Solnick J V, Schauer D B
Department of Internal Medicine, Division of Infectious Diseases, University of California, Davis, California 95616, USA.
Clin Microbiol Rev. 2001 Jan;14(1):59-97. doi: 10.1128/CMR.14.1.59-97.2001.
Since Helicobacter pylori was first cultivated from human gastric biopsy specimens in 1982, it has become apparent that many related species can often be found colonizing the mucosal surfaces of humans and other animals. These other Helicobacter species can be broadly grouped according to whether they colonize the gastric or enterohepatic niche. Gastric Helicobacter species are widely distributed in mammalian hosts and are often nearly universally prevalent. In many cases they cause an inflammatory response resembling that seen with H. pylori in humans. Although usually not pathogenic in their natural host, these organisms serve as models of human disease. Enterohepatic Helicobacter species are an equally diverse group of organisms that have been identified in the intestinal tract and the liver of humans, other mammals, and birds. In many cases they have been linked with inflammation or malignant transformation in immunocompetent hosts and with more severe clinical disease in immunocompromised humans and animals. The purpose of this review is to describe these other Helicobacter species, characterize their role in the pathogenesis of gastrointestinal and enterohepatic disease, and discuss their implications for our understanding of H. pylori infection in humans.
自1982年首次从人类胃活检标本中培养出幽门螺杆菌以来,很明显,经常可以发现许多相关菌种在人类和其他动物的黏膜表面定殖。这些其他幽门螺杆菌菌种可根据它们定殖于胃或肠肝生态位大致分组。胃幽门螺杆菌菌种广泛分布于哺乳动物宿主中,通常几乎普遍存在。在许多情况下,它们会引发一种类似于人类幽门螺杆菌感染所见的炎症反应。尽管这些微生物在其自然宿主中通常不致病,但它们可作为人类疾病的模型。肠肝幽门螺杆菌菌种是一组同样多样的微生物,已在人类、其他哺乳动物和鸟类的肠道及肝脏中被鉴定出来。在许多情况下,它们与免疫功能正常宿主的炎症或恶性转化有关,与免疫功能低下的人类和动物的更严重临床疾病有关。本综述的目的是描述这些其他幽门螺杆菌菌种,阐明它们在胃肠道和肠肝疾病发病机制中的作用,并讨论它们对我们理解人类幽门螺杆菌感染的意义。